Cliff Asness's VERA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 16,008 shares of Vera Therapeutics, Inc. (VERA) worth $644,001, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 7 quarters.
Based on 13F filings, Cliff Asness has maintained this position in VERA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 8,102 shares. Largest reduction occurred in Q2 2024, reducing 10,753 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Vera Therapeutics (VERA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vera Therapeutics (VERA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +8,102 | Add 102.48% | 16,008 | $40.23 |
| Q4 2025 | +7,906 | New Buy | 7,906 | $50.64 |
| Q1 2025 | -7,736 | Sold Out | 0 | $0.00 |
| Q4 2024 | +1,054 | Add 15.77% | 7,736 | $42.29 |
| Q3 2024 | -3,000 | Reduce 30.99% | 6,682 | $44.20 |
| Q2 2024 | -10,753 | Reduce 52.62% | 9,682 | $36.18 |
| Q1 2024 | +20,435 | New Buy | 20,435 | $43.12 |
Cliff Asness's Vera Therapeutics Investment FAQs
Cliff Asness first purchased Vera Therapeutics, Inc. (VERA) in Q1 2024, acquiring 20,435 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Vera Therapeutics, Inc. (VERA) for 7 quarters since Q1 2024.
Cliff Asness's largest addition to Vera Therapeutics, Inc. (VERA) was in Q1 2024, adding 20,435 shares worth $881,158.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 16,008 shares of Vera Therapeutics, Inc. (VERA), valued at approximately $644,001.
As of the Q1 2026 filing, Vera Therapeutics, Inc. (VERA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Vera Therapeutics, Inc. (VERA) was 20,435 shares, as reported at the end of Q1 2024.